Effects of benextramine on the adrenergic inhibition of insulin secretion in isolated rat pancreatic islets

in Journal of Molecular Endocrinology
View More View Less
Restricted access

ABSTRACT

Insulin secretion from isolated rat islets of Langerhans in the presence of 4 mm glucose averaged 2·26 ± 0·20 (s.e.m.) ng/islet per 90 min and was significantly (P<0·001; n=30) increased to 3·28 ± 0·21 ng/islet per 90 min by the covalent α-adrenoceptor antagonist benextramine (10 μm). Glucose (20 mm) also increased the secretion rate (to 6·24 ± 6·0 ng/islet per 90 min) but, under these conditions, the response was not further enhanced by benextramine. Clonidine and noradrenaline (1 nm–10 μm) each caused dose-dependent inhibition of glucose-induced insulin secretion which was maximal at 1 μm. Benextramine, when added simultaneously with the agonist, relieved, in a dosedependent manner, the inhibition of secretion induced by either clonidine or noradrenaline with similar sensitivity. Even after a 30-min preincubation with benextramine the antagonist failed to differentiate between noradrenaline, adrenaline and clonidine with respect to inhibition of insulin secretion. In contrast to its effects on adrenergic responses, short-term treatment with benextramine did not significantly affect muscarinic—cholinergic receptor-mediated 45Ca2+ efflux from rat islets of Langerhans perifused in Ca2+-depleted medium. These data suggest that benextramine does not differentiate between clonidine and noradrenaline in rat islets of Langerhans but that it does show preference for α-adrenoceptors in this tissue.

 

      Society for Endocrinology

Sept 2018 onwards Past Year Past 30 Days
Abstract Views 181 32 1
Full Text Views 120 0 0
PDF Downloads 20 0 0